Literature DB >> 19691734

Second look colonoscopy: indication and requirements.

Jean-Francois Rey1, Rene Lambert.   

Abstract

BACKGROUND: There are circumstances when a colonoscopy should be repeated after a short interval following the first endoscopic procedure which has not completely fulfilled its objective. REVIEW OF THE LITERATURE: A second look colonoscopy is proposed when there remains a doubt about missed neoplastic lesions, either because the intestinal preparation was poor or because the video-endoscope did not achieved a complete course in the colon. The second look colonoscopy is also proposed at a short interval when it is suspected that the endoscopic removal of a single or of multiple neoplastic lesions was incomplete and that a complement of treatment is required. When the initial endoscopic procedure has completely fulfilled its objective, a second look colonoscopy can be proposed at longer intervals in surveillance programs. The intervals in surveillance after polypectomy are now adapted to the initial findings according to established guidelines. This also applies to the surveillance of incident focal cancer in patients suffering from a chronic inflammatory bowel disease.
CONCLUSION: Finally, in most developed countries, a priority is attributed to screening of colorectal cancer and focus is given on quality assurance of colonoscopy which is considered as the gold standard procedure in the secondary prevention of colorectal cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19691734     DOI: 10.1111/j.1443-1661.2009.00859.x

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  1 in total

1.  Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.

Authors:  Esmée J Grobbee; Atija Kapidzic; Anneke J van Vuuren; Monique van Leerdam; Iris Lansdorp-Vogelaar; Caspar W N Looman; Marco J Bruno; Ernst J Kuipers; Manon C W Spaander
Journal:  Am J Gastroenterol       Date:  2015-06-09       Impact factor: 10.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.